This first-of-its-kind Guide To Expanded Access includes country-specific information on the availability of Expanded Access (EA), also known as compassionate use or pre-approval access, for 28 European countries, as well as Canada. It also describes the processes for requests in each country.

To learn more about the Guide, visit this Janssen Leadership blog post by Christine MacCracken, Head of Patient Strategies & Solutions, Janssen Pharmaceutical Companies of Johnson & Johnson and watch the brief video below, with Tom Watson and Naomi Litchfield of Bionical Emas who worked closely with Christine to develop the Guide.